SEQUENCING AND ARRAY-BASED SOLUTIONS FOR GENETIC RESEARCH
Illumina, Inc.
Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems dedicated to making genomics useful for all. Innovating at the intersection of technology, biology, and health, we are reimagining what’s possible for human health and the health of our planet, including how diseases—from cancer to COVID-19—are discovered, detected, diagnosed, and treated. We provide sequencing innovations that are enabling researchers and clinicians to usher in the future of personalized medicine.
Why Illumina
Illumina have made breakthroughs possible. As a genomics pioneer, Illumina have proven through focused and continued innovation how unlocking the power of the genome can exponentially improve the human condition and the world around us.
Illumina’s ability to drive patient outcomes has made them a trusted partner in health care. Today, Illumina’s providing tools that enable the next generation of researchers and clinicians to usher in the future of personalized medicine
FEATURED PRODUCT: ILLUMINA’S MOST ADVANCED NEXT-GENERATION SEQUENCING SYSTEM
NovaSeqTM X and NovaSeqTM X Plus
POWERED BY XLEAP-SBSTM CHEMISTRY
Our fastest, highest quality, and most robust sequencing by synthesis (SBS) chemistry to date. Built from the proven foundation of the most widely adopted and used SBS chemistry, XLEAP-SBS chemistry delivers improved reagent stability, up to 2× faster cycle times, and up to 3× greater accuracy.
ILLUMINA MAIN SEGMENTATIONS
Illumina Sequencing by Synthesis
Illumina sequencing utilizes a fundamentally different approach from the classic Sanger chain-termination method. It leverages sequencing by synthesis (SBS) technology – tracking the addition of labeled nucleotides as the DNA chain is copied – in a massively parallel fashion.
Infinium™ Microarrays Provide Outstanding Versatility
Hundreds of peer-reviewed scientific publications reference the trusted Infinium™ brand on an annual basis. Hear how customers are using Illumina’s microarray technology for myriad applications, in both research and applied settings.